Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancer

被引:0
|
作者
Melanie Spitzwieser
Elisabeth Holzweber
Georg Pfeiler
Stefan Hacker
Margit Cichna-Markl
机构
[1] University of Vienna,Department of Analytical Chemistry
[2] Medical University of Vienna,Department of Obstetrics and Gynecology, Division of Gynecology and Gynecological Oncology
[3] Medical University of Vienna,Department of Plastic and Reconstructive Surgery
来源
关键词
Methylation Status; Promoter Methylation; MGMT Promoter Methylation; Field Cancerization; RASSF1A Promoter;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancer
    Spitzwieser, Melanie
    Holzweber, Elisabeth
    Pfeiler, Georg
    Hacker, Stefan
    Cichna-Markl, Margit
    [J]. BREAST CANCER RESEARCH, 2015, 17
  • [2] Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome
    Xu, Jia
    Shetty, Priya B.
    Feng, Weiwei
    Chenault, Carol
    Bast, Robert C., Jr.
    Issa, Jean-Pierre J.
    Hilsenbeck, Susan G.
    Yu, Yinhua
    [J]. BMC CANCER, 2012, 12
  • [3] Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome
    Jia Xu
    Priya B Shetty
    Weiwei Feng
    Carol Chenault
    Robert C Bast
    Jean-Pierre J Issa
    Susan G Hilsenbeck
    Yinhua Yu
    [J]. BMC Cancer, 12
  • [4] Promoter methylation of HIN-1 in the progression to esophageal squamous cancer
    Guo, MingZhou
    Ren, JingLi
    Brock, Malcolm V.
    Herman, James G.
    Carraway, Hetty E.
    [J]. EPIGENETICS, 2008, 3 (06) : 336 - 341
  • [5] Prognostic significance of RASSF1A promoter methylation in operable breast cancer
    Kioulafa, Magdalini
    Kaklamanis, Loukas
    Mavroudis, Dimitris
    Georgoulias, Vassilis
    Lianidou, Evi S.
    [J]. CLINICAL BIOCHEMISTRY, 2009, 42 (10-11) : 970 - 975
  • [6] DNA methylation of RASSF1A, Hin-1, RAR-β, cyclin D2 and twist in in situ and invasive lobular breast carcinoma
    Fackler, MJ
    McVeigh, M
    Evron, E
    Garrett, E
    Mehrotra, J
    Polyak, K
    Sukumar, S
    Argani, P
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2003, 107 (06) : 970 - 975
  • [7] Methylation of RASSF1A, RASSF2A, and HIN-1 Is Associated with Poor Outcome after Radiotherapy, but not Surgery, in Oral Squamous Cell Carcinoma
    Huang, Kuo-Hao
    Huang, Shiang-Fu
    Chen, I-How
    Liao, Chun-Ta
    Wang, Hung-Ming
    Hsieh, Ling-Ling
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (12) : 4174 - 4180
  • [8] HIN-1 and the nosology of breast cancer
    Silver, DP
    [J]. CANCER BIOLOGY & THERAPY, 2003, 2 (05) : 564 - 565
  • [9] RASSF1A gene promoter methylation in esophageal cancer specimens
    Yamaguchi, S
    Kato, H
    Miyazaki, T
    Sohda, M
    Kimura, H
    Ide, M
    Asao, T
    Kuwano, H
    [J]. DISEASES OF THE ESOPHAGUS, 2005, 18 (04): : 253 - 256
  • [10] Detection of methylation in the CpG islands of the RASSF1A gene promoter in breast cancer (BC)
    Desiris, K. A.
    Voyatzi, S.
    Stravoravdi, P.
    Kiziridou, A.
    Paikos, D.
    Tremmas, I.
    Stergiou, E.
    Simbilidis, G.
    [J]. BREAST, 2009, 18 : S19 - S19